Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

Niro Ramachandran net worth and biography

Niro Ramachandran Biography and Net Worth

Insider of Akoya Biosciences

Niro joined Akoya in August 2020 to serve as the Chief Business Officer responsible for developing a robust roadmap and commercialization strategy for Akoya’s platforms. Niro has nearly two decades of experience in developing and commercializing products in the life science market. He has commercialized over 30 products across genomics and proteomics research markets. More recently, he served as the vice president of the spatial biology business unit at Nanostring Technologies (2014 – 2020). Prior to this, Niro led product development for the protein business unit at Life Technologies (2008-2014; acquired by Thermo Fisher). Niro received his Hon. BSc in Biochemistry from University of Toronto, and PhD from University of Windsor. He completed his post doctorate work at the Harvard Institute of Proteomics, Harvard University.

How old is Niro Ramachandran?: Dr. Ramachandran is currently 49 years old. There are 4 older executives and no younger executives at Akoya Biosciences. The oldest executive at Akoya Biosciences is Dr. Frederic G. Pla Ph.D., Chief Operating Officer, who is 65 years old. Learn More on Niro Ramachandran's age.
How do I contact Niro Ramachandran?: The corporate mailing address for Dr. Ramachandran and other Akoya Biosciences executives is , , . Akoya Biosciences can also be reached via phone at 855-896-8401 and via email at [email protected]. Learn More on Niro Ramachandran's contact information.
Has Niro Ramachandran been buying or selling shares of Akoya Biosciences?: Niro Ramachandran has not been actively trading shares of Akoya Biosciences during the past quarter. Learn More on Niro Ramachandran's trading history.
Who are Akoya Biosciences' active insiders?: Akoya Biosciences' insider roster includes Garry Nolan (Director), Niro Ramachandran (Insider), and Robert Shepler (Director). Learn More on Akoya Biosciences' active insiders.
Are insiders buying or selling shares of Akoya Biosciences?: In the last twelve months, Akoya Biosciences insiders bought shares 3 times. They purchased a total of 243,388 shares worth more than $1,208,940.00. In the last twelve months, insiders at the sold shares 4 times. They sold a total of 27,500 shares worth more than $136,475.00. The most recent insider tranaction occured on March, 20th when CEO Brian Mckelligon sold 7,500 shares worth more than $37,275.00. Insiders at Akoya Biosciences own 8.5% of the company. Learn More about insider trades at Akoya Biosciences.
Information on this page was last updated on 3/20/2024.

Niro Ramachandran Insider Trading History at Akoya Biosciences

Niro Ramachandran Buying and Selling Activity at Akoya Biosciences

Akoya Biosciences Company Overview

Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or FFPE tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers analysis software partnerships ecosystem; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.

Today's Range

Now: $3.80

$3.77

$3.97

50 Day Range

MA: $4.93

$3.80

$6.03

2 Week Range

Now: $3.80

$3.04

$8.80

Volume

172,101 shs

Average Volume

199,880 shs

Market Capitalization

$186.73 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.48

The “Perfect Storm” for Gold

From Gold Safe Exchange | Ad